Drug Utilization & Outcomes (DUO) Community

The Drug Utilization & Outcomes (DUO) Community brings together researchers from different disciplines who are interested in all aspects of research related to the safety, effectiveness, and utilization of therapeutics, as well as health outcomes, comparative effectiveness research, benefit-risk, risk management/mitigation, and pharmacoeconomics. 

Community Goals
The goal of the DUO Community is to promote collaboration among researchers and to facilitate integration of knowledge across different disciplines and over the medical product life-cycle to ultimately inform decisions on high quality, cost-effective, and patient-centered health care. The DUO Community provides opportunities to:
  • Discuss and exchange ideas among Community members.
  • Educate clinical pharmacologists on health outcomes, comparative effectiveness, and pharmacoeconomics topics.
  • Present examples of integrating safety, effectiveness, utilization, comparative effectiveness, health outcomes, and pharmacoeconomics knowledge to inform drug development and health care decisions.
  • Support Community/Network proposals for abstracts, workshops, symposia, and pre-conferences.
  • Promote collaboration with other key scientific stakeholders sharing similar goals.
New Community Vice Chair
Jing Liu, PhD, is currently a Senior Director of Clinical Pharmacology in Global Product Development at Pfizer, Inc., Groton, CT. Jing has a passion for model-informed drug development and has more than 18 years of experience in all stages of drug discovery and development. Jing joined ASCPT in 2003 and was a member of the Scientific Program Committee (2014-2016) and the Scientific Award Nomination Committee (2013-2015). In 2018, she co-chaired the pre-conference on “Pharmacometrics Meets Health Economics: Quantitative Approaches in the Translation from Efficacy to Real World Effectiveness and to Cost-effective Patient Care”. Contact Jing Liu.
Webinar ideas?
If you have a topic you would like to learn more about or to present, we encourage you to submit your input via the Webinar Proposal Submission portal.

Joshua J. Gagne, PharmD, ScD

Community Chair


Jing Liu, PhD

Community Vice Chair


Geert W. t'Jong, MD, PhD

Community Past Chair


Photo Gallery
Recent News
  • A Unique Collection of State-of-the-Art Pharmacometric and Systems Pharmacology Approaches in Rare Diseases Pharmacology and Therapeutics
    November 16, 2018
  • New Board Members Appointed
    November 15, 2018
  • ASCPT Members-Only Webinar Presented by the Pharmacogenomics Community (PGx)
    November 14, 2018
Contact Us